| 标题 |
 The landscape for therapeutic cancer vaccines |
| 备注 |
无
💡 该求助存在备注，如果存在信息冲突，请以备注为准
|
| 网址 | |
| DOI | |
| 其它 | Despite decades of effort, progress with therapeutic cancer vaccines has been limited by immune tolerance, heterogeneous antigenicity and modest clinical efficacy. However, recent advances in mRNA delivery, neoantigen prediction and rational immunotherapy combinations have shifted development toward more precise and programmable strategies (Nat. Rev. Cancer 25, 517–533; 2025). Here, we present an overview of clinical-stage vaccines, analysing the technology platforms, antigen selection and personalization approaches that could support the establishment of therapeutic cancer vaccines as a pillar of immuno-oncology. |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时，文件已从服务器自动删除，无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
嘻嘻哈哈
GingerF
AllRightReserved
loii
OK
2226
Scorpia112
wzhtnl
闪闪的忆枫
互助
张欢馨
jshmech
汉堡包
许靓仔
贪玩的秋柔
lizishu
无极微光
自由怜阳
学术文献互助
东方元语
皖公网安备34019202002308
